Patents by Inventor Helle Wittorff

Helle Wittorff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11903919
    Abstract: The present invention relates to an oral tablet for delivery of cannabinoids to mucosal surfaces comprising a population of particles and one or more cannabinoids, the population of particles comprising a) directly compressible (DC) sugar alcohol particles and b) non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas.
    Type: Grant
    Filed: February 18, 2021
    Date of Patent: February 20, 2024
    Assignee: NordicCan A/S
    Inventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen, Helle Wittorff
  • Publication number: 20230123099
    Abstract: The invention relates to an oral chewable tablet suitable for improved mouthfeel, comprising dextrose in an amount from 50 to 95% by weight of the tablet; one or more active ingredients; and one or more binders, wherein the ratio between the one or more binders and dextrose is from 1:250 to 1:8.
    Type: Application
    Filed: October 15, 2021
    Publication date: April 20, 2023
    Inventor: Helle WITTORFF
  • Patent number: 11484503
    Abstract: The invention relates to an oral delivery vehicle tablet, the delivery vehicle tablet being formed by compression of a plurality of particles, wherein the oral delivery vehicle tablet comprises sugar alcohol(s) in an amount of 40 to 99.9% by weight of the delivery vehicle tablet, wherein the oral delivery vehicle tablet comprises non-direct compressible (non-DC) erythritol particles in an amount of 15-50% by weight of the delivery vehicle tablet, wherein the oral delivery vehicle tablet comprises one or more binders other than binders granulated to the sugar alcohol(s) in an amount of 0.1 to 6% by weight of the tablet, wherein the delivery vehicle tablet comprises a plurality of further sugar alcohol particles in an amount of at least 10% by weight of the delivery vehicle tablet and wherein said further sugar alcohols particles have a composition which is different from said non-DC erythritol.
    Type: Grant
    Filed: November 13, 2019
    Date of Patent: November 1, 2022
    Assignee: FERTIN PHARMA A/S
    Inventor: Helle Wittorff
  • Publication number: 20220331222
    Abstract: Provided are methods of providing at least one oral care benefit by introducing a tablet into the oral cavity to generate a fluid and forcing at least a portion of fluid generated around the oral cavity, for example, by swishing, rinsing, washing, etc., to provide an oral care benefit.
    Type: Application
    Filed: May 31, 2022
    Publication date: October 20, 2022
    Inventors: Anthony R. Geonnotti, Patricia L. Golas, Helle Wittorff, Heidi Ziegler Bruun, Dorthe Shackinger Boesen
  • Patent number: 11351162
    Abstract: The invention relates an oral delivery vehicle tablet containing nicotine, the delivery vehicle tablet being formed by compression of a plurality of particles, the oral delivery vehicle tablet comprising nicotine, the oral delivery vehicle tablet comprising sugar alcohol(s) in an amount of 40 to 100% by weight of the delivery vehicle tablet, wherein at least 10% by weight of the delivery vehicle tablet comprises a plurality of particles consisting of erythritol and wherein the delivery vehicle tablet comprises a plurality of further sugar alcohol particles in an amount of at least 10% by weight of the delivery vehicle tablet, wherein said further sugar alcohol particles comprise at least one sugar alcohol and wherein said further sugar alcohols particles have a composition which is different from said particles consisting of erythritol.
    Type: Grant
    Filed: November 13, 2019
    Date of Patent: June 7, 2022
    Assignee: FERTIN PHARMA A/S
    Inventors: Helle Wittorff, Heidi Ziegler Bruun, Dorthe Schackinger Boesen
  • Patent number: 11351103
    Abstract: Provided are methods of providing at least one oral care benefit by introducing a tablet into the oral cavity to generate a fluid and forcing at least a portion of fluid generated around the oral cavity, for example, by swishing, rinsing, washing, etc., to provide an oral care benefit.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: June 7, 2022
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Anthony R. Geonnotti, Patricia L. Golas, Helle Wittorff, Heidi Ziegler Bruun, Dorthe Shackinger Boesen
  • Patent number: 11260030
    Abstract: An oral tablet for delivery of active ingredients to the gastrointestinal tract includes a population of particles and an active ingredient to be delivered to the gastrointestinal tract. The population of particles includes directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas, and the non-DC areas resulting in induced saliva generation upon mastication of the tablet, wherein the tablet is designed to be masticated and designed to deliver the active ingredient to the gastrointestinal tract as part of the saliva generated upon mastication of the tablet.
    Type: Grant
    Filed: June 10, 2021
    Date of Patent: March 1, 2022
    Assignee: Fertin Pharma A/S
    Inventor: Helle Wittorff
  • Publication number: 20210346263
    Abstract: A mouthwash and method for oral care benefits includes a swishable powder delivery system having a content of at least two types of sugar alcohol particles with different particle size distributions and one or more active ingredients, the powder delivery system being a dry and flowable population of particles suitable for resembling a liquid mouthwash by swishing the powder delivery system, thereby generating fluid in the oral cavity without adding water.
    Type: Application
    Filed: April 30, 2021
    Publication date: November 11, 2021
    Applicant: Fertin Pharma A/S
    Inventors: Helle Wittorff, Christine Nøhr Pedersen
  • Publication number: 20210346257
    Abstract: A powder mixture for oral delivery of active ingredients includes a population of particles and one or more active ingredients, the population of particles including at least two types of sugar alcohol particles. At least one of the at least two types of sugar alcohol particles takes the form of i) non-directly compressible (non-DC) sugar alcohol particles or ii) directly compressible (DC) sugar alcohol particles that are not granulated sugar alcohol particles. At least one of the at least two types of sugar alcohol particles has a particle size with more than 50% of the particles being below 250 microns, and at least one of the at least two types of sugar alcohol particles is present in an amount of at least 20% by weight of the powder mixture.
    Type: Application
    Filed: April 30, 2021
    Publication date: November 11, 2021
    Applicant: Fertin Pharma A/S
    Inventors: Helle Wittorff, Christine Nøhr Pedersen
  • Publication number: 20210346295
    Abstract: A flowpack for oral delivery of active ingredients comprises a population of particles and one or more active ingredients, the population of particles including at least two types of sugar alcohol particles, wherein at least one of said two types of sugar alcohol particles comprises granulated sugar alcohol particles.
    Type: Application
    Filed: April 30, 2021
    Publication date: November 11, 2021
    Inventors: Helle WITTORFF, Christine Nøhr Pedersen
  • Patent number: 11135157
    Abstract: The invention relates to an oral tablet for delivery of active ingredients to the throat comprising a population of particles and an active ingredient to be delivered to the throat, the population of particles comprising directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas, the non-DC areas resulting in induced saliva generation upon mastication of the tablet, wherein the tablet is designed to be masticated and designed to deliver the active ingredient to the throat as part of the saliva generated upon mastication of the tablet.
    Type: Grant
    Filed: May 17, 2018
    Date of Patent: October 5, 2021
    Assignee: FERTIN PHARMA A/S
    Inventor: Helle Wittorff
  • Publication number: 20210299052
    Abstract: An oral tablet for delivery of active ingredients to the gastrointestinal tract includes a population of particles and an active ingredient to be delivered to the gastrointestinal tract. The population of particles includes directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas, and the non-DC areas resulting in induced saliva generation upon mastication of the tablet, wherein the tablet is designed to be masticated and designed to deliver the active ingredient to the gastrointestinal tract as part of the saliva generated upon mastication of the tablet.
    Type: Application
    Filed: June 10, 2021
    Publication date: September 30, 2021
    Applicant: Fertin Pharma A/S
    Inventor: Helle Wittorff
  • Publication number: 20210290530
    Abstract: A disintegrating oral tablet suitable for active pharmaceutical ingredients includes a population of particles and at least one flavor ingredient. The population of particles includes directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas, and the non-DC areas resulting in a burst of the at least one flavor ingredient upon mastication of the tablet.
    Type: Application
    Filed: June 9, 2021
    Publication date: September 23, 2021
    Applicant: Fertin Pharma A/S
    Inventor: Helle Wittorff
  • Publication number: 20210290547
    Abstract: An oral tablet for taste masking of active ingredients includes a population of particles and an active ingredient with off-note taste. The population of particles includes directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas, and the non-DC areas resulting at least partly in induced taste masking of the active ingredient upon mastication of the tablet.
    Type: Application
    Filed: June 8, 2021
    Publication date: September 23, 2021
    Applicant: Fertin Pharma A/S
    Inventor: Helle Wittorff
  • Publication number: 20210267933
    Abstract: The present invention relates to an oral tablet for delivery of cannabinoids to mucosal surfaces comprising a population of particles and one or more cannabinoids, the population of particles comprising a) directly compressible (DC) sugar alcohol particles and b) non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas.
    Type: Application
    Filed: February 18, 2021
    Publication date: September 2, 2021
    Inventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen, Helle Wittorff
  • Patent number: 11096895
    Abstract: The invention relates to an oral delivery tablet suitable for active pharmaceutical ingredients comprising a population of particles, the population of particles comprising a) directly compressible (DC) sugar alcohol particles, b) non-directly compressible (non-DC) sugar alcohol particles and c) particles comprising gum base, the non-DC particles providing the tablet with a plurality of discrete non-DC areas, and the non-DC areas resulting in induced saliva generation upon mastication of the tablet, wherein the tablet is designed to be masticated into a coherent residual containing water-insoluble components.
    Type: Grant
    Filed: May 17, 2018
    Date of Patent: August 24, 2021
    Inventor: Helle Wittorff
  • Patent number: 11096894
    Abstract: The invention relates to an oral tablet suitable for active pharmaceutical ingredients comprising a population of particles, the population of particles comprising directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas, and the non-DC areas resulting in induced saliva generation upon mastication of the tablet.
    Type: Grant
    Filed: May 17, 2018
    Date of Patent: August 24, 2021
    Inventor: Helle Wittorff
  • Patent number: 11096896
    Abstract: The invention relates to a tablet dosage form for buccal absorption of active ingredients comprising a population of particles and an active ingredient to be released in the oral cavity for absorption through the oral mucosa, the population of particles comprising directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas.
    Type: Grant
    Filed: May 17, 2018
    Date of Patent: August 24, 2021
    Inventor: Helle Wittorff
  • Patent number: 11090263
    Abstract: The invention relates to a tableted chewing gum suitable for active pharmaceutical ingredients, the chewing gum comprising a population of particles, the population of particles comprising a) directly compressible (DC) sugar alcohol particles, b) non-directly compressible (non-DC) sugar alcohol particles and c) particles comprising gum base, the gum base comprising at least 5% by weight of elastomer.
    Type: Grant
    Filed: May 22, 2018
    Date of Patent: August 17, 2021
    Assignee: FERTIN PHARMA A/S
    Inventor: Helle Wittorff
  • Patent number: 11058641
    Abstract: The invention relates to an oral tablet for taste masking of active ingredients, the tablet comprising a population of particles and an active ingredient with off-note taste, the population of particles comprising directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas, and the non-DC areas resulting at least partly in induced taste masking of the active ingredient upon mastication of the tablet.
    Type: Grant
    Filed: May 17, 2018
    Date of Patent: July 13, 2021
    Assignee: Fertin Pharma A/S
    Inventor: Helle Wittorff